EcoDrugPlus

Cathepsin L1-Like

Ensembl ID : ENSMMDG00005015075
Gene Symbol: LOC115374320
3 Cross references
235 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSMMDG00005005316
Gene Symbol: LOC115367396
2 Cross references
183 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSMMDG00005008375
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSMMDG00005011535
Gene Symbol: CHEK1
1 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSMMDG00005006336
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSMMDG00005015984
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSMMDG00005004050
Gene Symbol: CCKBR
1 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSMMDG00005003078
Gene Symbol: LOC115373824
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSMMDG00005011408
Gene Symbol: LOC115355777
2 Cross references
255 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSMMDG00005011269
Gene Symbol: LOC115355783
2 Cross references
255 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSMMDG00005011533
Gene Symbol: LOC115355782
2 Cross references
255 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSMMDG00005003537
Gene Symbol: CETP
1 Cross references
137 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).